|Last Price||Today's Change||52-Week Range||Trading Volume|
|6.30 CAD||0.15 (+2.44%)||2.40 - 7.85||3.1 thousand|
Market data as of 3:54PM 10/24/14. Quotes are delayed by at least 15 min.
Neovasc Receives FDA Conditional Approval to Initiate TIARA-I Trial in US: A Multinational, Multicenter Early Feasibility Trial of the Tiara™ Transcatheter Mitral Valve
PR Newswire - Thursday 10/09/2014 7:00 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.